For over two decades Umbrella Corporation has delivered pharmaceutical products, speciality chemicals and healthcare services to partners across Europe and beyond.
Integrated operations across research, manufacturing and patient care.
Development and licensed manufacture of small-molecule therapeutics, with a focus on anti-viral and regenerative treatment programmes.
Read more ›Speciality and fine chemicals for industrial, agricultural and laboratory use, produced under strict European compliance frameworks.
Read more ›Clinical services, occupational health programmes and diagnostic support for corporate and institutional clients.
Read more ›Umbrella Corporation was founded in 1998 as a single research laboratory and has since grown into a group of three operating entities across Ireland, Germany and the United Kingdom. Our structure is deliberately conservative: long product lifecycles, long partnerships, and long-term investment in facilities.
We supply more than four hundred institutional customers, from regional hospital groups to industrial manufacturers. Our compliance record and our willingness to take on complex, low-volume programmes are what most clients tell us they value.
Corporate announcements and regulatory notices.
Press Release
Umbrella Chemical GmbH has completed the second phase of its reactor hall refurbishment, adding 18% batch capacity.
Regulatory
The group's consolidated compliance filing for the reporting period has been submitted to the relevant authorities in all three jurisdictions.
Corporate
The board has approved the expansion of analytical laboratory space at the Umbrella Pharma facility in Dublin.